Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W M Bennett

Showing results (351-360 of 371) with videos related to

Pageof 38
Sort By:
Medicine|July 1, 1988
Dialysis in the management of pregnant patients with renal insufficiencyM Redrow, L Cherem, J Elliott, et al.
Journal of Cardiovascular Pharmacology|June 1, 1988
Cyclosporin A and pressor responsiveness in sheepJ J de Lima, W M Bennett, J P Coghlan, et al.
The American Journal of Physiology|October 1, 1995
Prevention of experimental cyclosporin-induced interstitial fibrosis by losartan and enalaprilE A Burdmann, T F Andoh, C C Nast, et al.
Journal of Environmental Pathology and Toxicology|November 1, 1980
Amikacin nephrotoxicity in the ratD C Houghton, C E Plamp, D N Gilbert, et al.
The Journal of Infectious Diseases|May 1, 1989
Polyaspartic acid prevents experimental aminoglycoside nephrotoxicityD N Gilbert, C A Wood, S J Kohlhepp, et al.
Transplantation Proceedings|October 1, 1994
Mechanisms of cyclosporine-induced interstitial fibrosisE A Burdmann, B Young, T F Andoh, et al.
Clinical Transplants|January 1, 1991
Outcome of renal transplantation at Oregon Health Sciences University: 1982 to 1990D J Norman, W M Bennett, P J Wetzsteon, et al.
Transplantation|February 15, 1995
Delayed omega-3 fatty acid supplements in renal transplantation. A double-blind, placebo-controlled studyW M Bennett, C B Carpenter, M E Shapiro, et al.
Pharmacotherapy|January 1, 1992
Zidovudine pharmacokinetics in five HIV seronegative patients undergoing continuous ambulatory peritoneal dialysisD Kremer, M Y Munar, S J Kohlhepp, et al.
Transplantation|September 12, 1998
Efficacy and safety of low molecular weight heparin in renal transplantationA M Alkhunaizi, A J Olyaei, J M Barry, et al.
Pageof 38

Showing results (351-360 of 371) with videos related to

Sort By:
Pageof 38
Medicine|July 1, 1988
Dialysis in the management of pregnant patients with renal insufficiencyM Redrow, L Cherem, J Elliott, et al.
Journal of Cardiovascular Pharmacology|June 1, 1988
Cyclosporin A and pressor responsiveness in sheepJ J de Lima, W M Bennett, J P Coghlan, et al.
The American Journal of Physiology|October 1, 1995
Prevention of experimental cyclosporin-induced interstitial fibrosis by losartan and enalaprilE A Burdmann, T F Andoh, C C Nast, et al.
Journal of Environmental Pathology and Toxicology|November 1, 1980
Amikacin nephrotoxicity in the ratD C Houghton, C E Plamp, D N Gilbert, et al.
The Journal of Infectious Diseases|May 1, 1989
Polyaspartic acid prevents experimental aminoglycoside nephrotoxicityD N Gilbert, C A Wood, S J Kohlhepp, et al.
Transplantation Proceedings|October 1, 1994
Mechanisms of cyclosporine-induced interstitial fibrosisE A Burdmann, B Young, T F Andoh, et al.
Clinical Transplants|January 1, 1991
Outcome of renal transplantation at Oregon Health Sciences University: 1982 to 1990D J Norman, W M Bennett, P J Wetzsteon, et al.
Transplantation|February 15, 1995
Delayed omega-3 fatty acid supplements in renal transplantation. A double-blind, placebo-controlled studyW M Bennett, C B Carpenter, M E Shapiro, et al.
Pharmacotherapy|January 1, 1992
Zidovudine pharmacokinetics in five HIV seronegative patients undergoing continuous ambulatory peritoneal dialysisD Kremer, M Y Munar, S J Kohlhepp, et al.
Transplantation|September 12, 1998
Efficacy and safety of low molecular weight heparin in renal transplantationA M Alkhunaizi, A J Olyaei, J M Barry, et al.
Pageof 38